BTR Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $227K | Sell |
545
-50
| -8% | -$20.8K | 0.04% | 151 |
|
|
2022
Q2 | $295K | Buy |
595
+80
| +16% | +$39.7K | 0.04% | 138 |
|
|
2022
Q1 | $290K | Sell |
515
-85
| -14% | -$47.9K | 0.04% | 144 |
|
|
2021
Q4 | $453K | Hold |
600
| – | – | 0.05% | 128 |
|
|
2021
Q3 | $448K | Hold |
600
| – | – | 0.06% | 121 |
|
|
2021
Q2 | $387K | Buy |
600
+180
| +43% | +$116K | 0.05% | 132 |
|
|
2021
Q1 | $240K | Sell |
420
-170
| -29% | -$97.1K | 0.03% | 152 |
|
|
2020
Q4 | $344K | Hold |
590
| – | – | 0.05% | 130 |
|
|
2020
Q3 | $304K | Hold |
590
| – | – | 0.05% | 124 |
|
|
2020
Q2 | $266K | Hold |
590
| – | – | 0.05% | 130 |
|
|
2020
Q1 | $207K | Sell |
590
-100
| -14% | -$35.1K | 0.05% | 140 |
|
|
2019
Q4 | $255K | Hold |
690
| – | – | 0.04% | 144 |
|
|
2019
Q3 | $230K | Hold |
690
| – | – | 0.04% | 147 |
|
|
2019
Q2 | $216K | Sell |
690
-2,430
| -78% | -$761K | 0.04% | 155 |
|
|
2019
Q1 | $954K | Buy |
3,120
+150
| +5% | +$45.9K | 0.18% | 85 |
|
|
2018
Q4 | $690K | Hold |
2,970
| – | – | 0.15% | 93 |
|
|
2018
Q3 | $930K | Hold |
2,970
| – | – | 0.16% | 83 |
|
|
2018
Q2 | $857K | Hold |
2,970
| – | – | 0.17% | 78 |
|
|
2018
Q1 | $743K | Hold |
2,970
| – | – | 0.15% | 85 |
|
|
2017
Q4 | $709K | Hold |
2,970
| – | – | 0.14% | 87 |
|
|
2017
Q3 | $660K | Hold |
2,970
| – | – | 0.13% | 87 |
|
|
2017
Q2 | $672K | Sell |
2,970
-220
| -7% | -$49.8K | 0.14% | 87 |
|
|
2017
Q1 | $636K | Hold |
3,190
| – | – | 0.13% | 89 |
|
|
2016
Q4 | $523K | Hold |
3,190
| – | – | 0.12% | 107 |
|
|
2016
Q3 | $523K | Buy |
+3,190
| New | +$523K | 0.12% | 107 |
|